Contratos
Contract
Phase I trial of DNX-2440 oncolytic adenovirus in patients w
date_range
Duration: from 07 May 2018 to 30 June 2024
(74 months)
euro
105,000.00 EUR
Of International (non-EU) scope.
Researchers
Marta María
Alonso Roldán
Leader